Invesco
EOLS icon

Invesco’s Evolus EOLS Stock Holding History

Invesco’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$246K Sell
35,493
-842
-2% -$4.97K ﹤0.01% 3511
2026
Q1 		$149K Buy
36,335
+2,216
+6% +$10.7K ﹤0.01% 3563
2025
Q4 		$227K Buy
34,119
+451
+1% +$3.06K ﹤0.01% 3483
2025
Q3 		$207K Sell
33,668
-615
-2% -$4.79K ﹤0.01% 3557
2025
Q2 		$316K Buy
34,283
+2,383
+7% +$24.4K ﹤0.01% 3343
2025
Q1 		$384K Buy
31,900
+13,574
+74% +$178K ﹤0.01% 3259
2024
Q4 		$202K Sell
18,326
-83,072
-82% -$1.17M ﹤0.01% 3510
2024
Q3 		$1.64M Buy
101,398
+84,120
+487% +$1.18M ﹤0.01% 2686
2024
Q2 		$187K Sell
17,278
-81,347
-82% -$1M ﹤0.01% 3639
2024
Q1 		$1.38M Buy
98,625
+84,262
+587% +$1.1M ﹤0.01% 2845
2023
Q4 		$151K Sell
14,363
-2,624
-15% -$23.5K ﹤0.01% 3616
2023
Q3 		$155K Buy
16,987
+258
+2% +$2.31K ﹤0.01% 3655
2023
Q2 		$122K Buy
16,729
+820
+5% +$7.07K ﹤0.01% 3693
2023
Q1 		$135K Buy
15,909
+567
+4% +$5.13K ﹤0.01% 3684
2022
Q4 		$115K Sell
15,342
-152,921
-91% -$1.18M ﹤0.01% 3801
2022
Q3 		$1.35M Buy
168,263
+32,447
+24% +$344K ﹤0.01% 2804
2022
Q2 		$1.57M Sell
135,816
-12,602
-8% -$149K ﹤0.01% 2801
2022
Q1 		$1.67M Buy
148,418
+136,159
+1,111% +$1.16M ﹤0.01% 2855
2021
Q4 		$80K Buy
12,259
+681
+6% +$4.67K ﹤0.01% 3926
2021
Q3 		$88K Sell
11,578
-141,492
-92% -$1.46M ﹤0.01% 3956
2021
Q2 		$1.94M Sell
153,070
-407,354
-73% -$4.48M ﹤0.01% 2865
2021
Q1 		$7.28M Buy
+560,424
New +$5.17M ﹤0.01% 2162

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Invesco's EOLS Position: Q2 2026 in Review

Invesco reduced its Evolus (EOLS) stake by 2.3% in Q2 2026, selling an estimated $4.97K and leaving 35,493 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #3511.

Invesco first reported a position in EOLS in Q1 2021 and has held it in 22 quarters since. The position peaked at $7.28M in Q1 2021. 159 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

  • Invesco held 35,493 shares of Evolus worth $246K as of Q2 2026.
  • Invesco sold 842 Evolus shares in Q2 2026, an estimated $4.97K.
  • Evolus made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3511 holding.
  • Invesco first reported a position in Evolus in Q1 2021 and has held it in 22 quarters since.
  • Invesco's Evolus position peaked at $7.28M in Q1 2021.
  • 159 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.